Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.

Conditions: Neuroendocrine Carcinoma Interventions: Biological: ZG005; Drug: Etoposide; Drug: Cisplatin; Drug: Placebo Sponsors: Suzhou Zelgen Biopharmaceuticals Co.,Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials